• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

城市内医疗服务提供机构中肥胖的新冠患者的临床转归和炎症标志物水平。

Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital.

机构信息

Department of Internal Medicine, School of Medicine, Boston University, Boston, Massachusetts, United States of America.

Section of Infectious Diseases, Department of Internal Medicine, School of Medicine, Boston University, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2020 Dec 16;15(12):e0243888. doi: 10.1371/journal.pone.0243888. eCollection 2020.

DOI:10.1371/journal.pone.0243888
PMID:33326480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7744045/
Abstract

OBJECTIVES

Patients with Covid-19 and obesity have worse clinical outcomes which may be driven by increased inflammation. This study aimed to characterize the association between clinical outcomes in patients with obesity and inflammatory markers.

METHODS

We analyzed data for patients aged ≥18 years admitted with a positive SARS-CoV-2 PCR test. We used multivariate logistic regression to determine the association between BMI and intensive care unit (ICU) transfer and all-cause mortality. Inflammatory markers (C-reactive protein [CRP], lactate dehydrogenase [LDH], ferritin, and D-dimer) were compared between patients with and without obesity (body mass index [BMI] ≥30 kg/m2).

RESULTS

Of 791 patients with Covid-19, 361 (45.6%) had obesity. In multivariate analyses, BMI ≥35 was associated with a higher odds of ICU transfer (adjusted odds ratio [aOR] 2.388 (95% confidence interval [CI]: 1.074-5.310) and hospital mortality (aOR = 4.3, 95% CI: 1.69-10.82). Compared to those with BMI<30, patients with obesity had lower ferritin (444 vs 637 ng/mL; p<0.001) and lower D-dimer (293 vs 350 mcg/mL; p = 0.009), non-significant differences in CRP (72.8 vs 84.1 mg/L, p = 0.099), and higher LDH (375 vs 340, p = 0.009) on the first hospital day.

CONCLUSIONS

Patients with obesity were more likely to have poor outcomes even without increased inflammation.

摘要

目的

患有新冠肺炎和肥胖症的患者临床结局更差,这可能是由炎症增加引起的。本研究旨在描述肥胖患者的临床结局与炎症标志物之间的关联。

方法

我们分析了年龄≥18 岁并经 SARS-CoV-2 PCR 检测呈阳性的患者数据。我们使用多变量逻辑回归来确定 BMI 与重症监护病房(ICU)转科和全因死亡率之间的关系。比较了肥胖症患者(BMI≥30kg/m2)与非肥胖症患者之间的炎症标志物(C 反应蛋白[CRP]、乳酸脱氢酶[LDH]、铁蛋白和 D-二聚体)。

结果

在 791 例新冠肺炎患者中,有 361 例(45.6%)患有肥胖症。在多变量分析中,BMI≥35 与 ICU 转科的几率更高相关(调整后的优势比[aOR]为 2.388(95%置信区间[CI]:1.074-5.310)和医院死亡率(aOR=4.3,95%CI:1.69-10.82)。与 BMI<30 的患者相比,肥胖症患者的铁蛋白(444 vs 637ng/mL;p<0.001)和 D-二聚体(293 vs 350mcg/mL;p=0.009)更低,C 反应蛋白(72.8 vs 84.1mg/L,p=0.099)无显著差异,乳酸脱氢酶(375 vs 340,p=0.009)更高,入院第一天。

结论

即使没有炎症增加,肥胖症患者的预后也更差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7707/7744045/7d779c8f275a/pone.0243888.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7707/7744045/7d779c8f275a/pone.0243888.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7707/7744045/7d779c8f275a/pone.0243888.g001.jpg

相似文献

1
Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital.城市内医疗服务提供机构中肥胖的新冠患者的临床转归和炎症标志物水平。
PLoS One. 2020 Dec 16;15(12):e0243888. doi: 10.1371/journal.pone.0243888. eCollection 2020.
2
Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden-A cohort study.肥胖对瑞典 COVID-19 患者重症监护结局的影响:一项队列研究。
PLoS One. 2021 Oct 13;16(10):e0257891. doi: 10.1371/journal.pone.0257891. eCollection 2021.
3
Obesity as a mortality risk factor in the medical ward: a case control study.肥胖作为医疗病房死亡风险因素:病例对照研究。
BMC Endocr Disord. 2022 Jan 6;22(1):13. doi: 10.1186/s12902-021-00912-5.
4
The role of obesity in inflammatory markers in COVID-19 patients.肥胖在 COVID-19 患者炎症标志物中的作用。
Obes Res Clin Pract. 2021 Jan-Feb;15(1):96-99. doi: 10.1016/j.orcp.2020.12.004. Epub 2020 Dec 23.
5
Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study.肥胖与 COVID-19 住院患者疾病严重程度的关联:一项回顾性队列研究。
Obes Res Clin Pract. 2021 Mar-Apr;15(2):172-176. doi: 10.1016/j.orcp.2021.02.006. Epub 2021 Feb 25.
6
Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.入院时铁蛋白水平升高可预测 COVID-19 患者的重症监护病房死亡率。
Med Clin (Barc). 2021 Apr 9;156(7):324-331. doi: 10.1016/j.medcli.2020.11.030. Epub 2020 Dec 25.
7
Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach.COVID-19 肺炎患者接受无创/有创通气支持的风险因素:多学科方法的回顾性研究。
Int J Infect Dis. 2020 Nov;100:258-263. doi: 10.1016/j.ijid.2020.09.012. Epub 2020 Sep 11.
8
The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.菲律宾 CORONA 研究中糖尿病患者的结局。
Sci Rep. 2021 Dec 24;11(1):24436. doi: 10.1038/s41598-021-03898-1.
9
Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York.来自纽约市一所教学医院的非裔美国人 COVID-19 患者的临床特征和死亡预测因素。
J Med Virol. 2021 Feb;93(2):812-819. doi: 10.1002/jmv.26306. Epub 2020 Oct 5.
10
[Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].[老年重症新型冠状病毒肺炎患者继发噬血细胞性淋巴组织细胞增生症的临床特征及危险因素:一项多中心回顾性队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):793-799. doi: 10.3760/cma.j.cn121430-20230510-00158.

引用本文的文献

1
Prognostic value of C-reactive protein levels in pulmonary infections: A systematic review and meta-analysis.C反应蛋白水平在肺部感染中的预后价值:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Mar 21;104(12):e41722. doi: 10.1097/MD.0000000000041722.
2
Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review.肥胖作为 SARS-CoV-2 感染者并发症和死亡的风险因素:系统综述。
Nutrients. 2024 Feb 16;16(4):543. doi: 10.3390/nu16040543.
3
Obesity as an independent risk factor for COVID-19 severity and mortality.

本文引用的文献

1
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.肥胖与 COVID-19 患者:流行病学和生物学关系的全球视角。
Obes Rev. 2020 Nov;21(11):e13128. doi: 10.1111/obr.13128. Epub 2020 Aug 26.
2
Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients.肥胖患者脂肪组织中ACE2的高水平基因表达与COVID-19感染死亡率的关联。
Obes Med. 2020 Sep;19:100283. doi: 10.1016/j.obmed.2020.100283. Epub 2020 Jul 18.
3
Obese communities among the best predictors of COVID-19-related deaths.
肥胖是 COVID-19 严重程度和死亡率的独立危险因素。
Cochrane Database Syst Rev. 2023 May 24;5(5):CD015201. doi: 10.1002/14651858.CD015201.
4
Role of cystatin C and calprotectin as potential early prognostic biomarkers in COVID-19 patients admitted to a dedicated COVID care facility.胱抑素C和钙卫蛋白作为入住专门新冠护理机构的新冠患者潜在早期预后生物标志物的作用。
J Family Med Prim Care. 2022 Jul;11(7):3971-3979. doi: 10.4103/jfmpc.jfmpc_545_22. Epub 2022 Jul 22.
5
Molecular aspects of COVID-19 and its relationship with obesity and physical activity: a narrative review.新型冠状病毒肺炎的分子机制及其与肥胖和体力活动的关系:一项叙述性综述。
Sao Paulo Med J. 2023 Jan-Feb;141(1):78-86. doi: 10.1590/1516-3180.2021.1038.R1.06072022.
6
COVID-19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances.COVID-19、肥胖与大流行后 2 年的免疫反应:科学进展时间表。
Obes Rev. 2022 Oct;23(10):e13496. doi: 10.1111/obr.13496. Epub 2022 Jul 15.
7
Obesity, Inflammation, and Mortality in COVID-19: An Observational Study from the Public Health Care System of New York City.肥胖、炎症与新冠病毒感染的死亡率:来自纽约市公共医疗系统的一项观察性研究。
J Clin Med. 2022 Jan 26;11(3):622. doi: 10.3390/jcm11030622.
8
Mechanisms contributing to adverse outcomes of COVID-19 in obesity.导致肥胖患者 COVID-19 不良结局的机制。
Mol Cell Biochem. 2022 Apr;477(4):1155-1193. doi: 10.1007/s11010-022-04356-w. Epub 2022 Jan 27.
9
Associations of Body Mass Index with Ventilation Management and Clinical Outcomes in Invasively Ventilated Patients with ARDS Related to COVID-19-Insights from the PRoVENT-COVID Study.体重指数与2019冠状病毒病相关急性呼吸窘迫综合征有创通气患者通气管理及临床结局的关联——来自PRoVENT-COVID研究的见解
J Clin Med. 2021 Mar 11;10(6):1176. doi: 10.3390/jcm10061176.
肥胖群体是与新冠病毒相关死亡的最佳预测指标之一。
Cardiovasc Endocrinol Metab. 2020 Jun 11;9(3):102-107. doi: 10.1097/XCE.0000000000000218. eCollection 2020 Sep.
4
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study.体重指数与 SARS-CoV-2 感染患者气管插管或死亡风险:一项回顾性队列研究。
Ann Intern Med. 2020 Nov 17;173(10):782-790. doi: 10.7326/M20-3214. Epub 2020 Jul 29.
5
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.早期给予白细胞介素 6 抑制剂治疗重症 COVID-19 患者与降低插管率、降低死亡率和增加出院率相关。
Int J Infect Dis. 2020 Oct;99:28-33. doi: 10.1016/j.ijid.2020.07.023. Epub 2020 Jul 25.
6
Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19.内脏脂肪与 COVID-19 患者需要重症监护的关联性最强。
Metabolism. 2020 Oct;111:154319. doi: 10.1016/j.metabol.2020.154319. Epub 2020 Jul 23.
7
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
8
Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.鼻咽拭子和唾液检测严重急性呼吸综合征冠状病毒 2 的敏感性。
Clin Infect Dis. 2021 Mar 15;72(6):1064-1066. doi: 10.1093/cid/ciaa848.
9
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
10
COVID-19 and the role of chronic inflammation in patients with obesity.新型冠状病毒肺炎与肥胖患者慢性炎症的关系。
Int J Obes (Lond). 2020 Aug;44(8):1790-1792. doi: 10.1038/s41366-020-0597-4. Epub 2020 May 14.